Narcolepsy and excessive daytime sleepiness
Adam Zeman,Tom Britton,Neil J. Douglas,Andrew Hansen,Jane Hicks,Robin S. Howard,Andrew Meredith,Ian E. Smith,Gregory Stores,Sue Wilson,Zenobia Zaiwalla +10 more
TL;DR: An update on the biology, diagnosis, and management of narcolepsy—an important, yet often misdiagnosed, cause of sleepiness that has seen exciting recent advances is provided.
read more
Abstract: Excessive daytime sleepiness is common,1 yet opportunities to learn about sleep medicine in medical school are rare; a survey in 1998 indicated that undergraduate courses devoted a median of five minutes to sleep and its disorders2 In this review we provide an update on the biology, diagnosis, and management of narcolepsy—an important, yet often misdiagnosed, cause of sleepiness that has seen exciting recent advances We also briefly outline the other principal causes of daytime sleepiness and aim to equip the general reader with a practical approach to the assessment of patients who complain of excessive daytime sleepiness
This paper is based on a literature search conducted to produce evidence based guidelines on the diagnosis and management of narcolepsy in adults and children3 We searched Medline, Embase, the Cochrane Collaboration, and two specialist sleep literature resources for abstracts with the key word “narcolepsy” We read the full text of relevant papers and hand searched these for other relevant material A multidisciplinary working party prepared the guidelines, and a group of 10 independent experts later reviewed them These guidelines can be downloaded from the news section of http://wwwsleepingorguk/ (accessed July 2004)
Narcolepsy is a chronic neurological disorder affecting sleep regulation and causing excessive sleepiness and, in most cases, cataplexy (brief attacks of weakness on emotional arousal)3 4 The excessive sleepiness of narcolepsy comprises both a background feeling of sleepiness present much of the time and a strong, sometime irresistible, urge to sleep recurring at intervals through the day This desire is heightened by conducive, monotonous circumstances, but naps at inappropriate times—such as during meals—are characteristic The naps of narcolepsy usually last from minutes to an hour and occur a few times each day Cataplexy refers to partial or generalised, almost invariably bilateral, loss of skeletal muscle tone and …
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Treating Narcolepsy and Idiopathic Hypersomnia
Tony J. Masri,Vikas Jain,Christian Guilleminault +2 more
- 01 Jan 2018
TL;DR: This chapter will review the treatment of narcolepsy and idiopathic hypersomnia, and discuss presently available and emerging treatment options for nar colepsy.
Occupational Medicine Forum
TL;DR: The Occupational Medicine Forum is prepared by the ACOEM Occupational and Environmental Medical Practice Committee and does not necessarily represent an official ACO EM position.
Psychiatric Aspects of Organic Sleep Disorders
José Haba-Rubio
TL;DR: This study reviews the relationship between organic sleep disorders and psychiatric morbidity, finding a strong association with mood disorders, particularly depression, and a negative impact on health-related quality of life across various sleep disorders.
•Journal Article
Psychiatric aspects of organic sleep disorders.
TL;DR: Generally, it can be concluded that organic sleep disorders have a profound negative impact on most domains of health-related quality of life.
Sodium oxybate: a review of its use in the management of narcolepsy.
TL;DR: Sodium oxybate is highly effective in reducing the frequency of cataplexy, improving sleep architecture and reducing EDS in patients with narcolepsy, and offers a valuable alternative or addition to the use of TCAs, SSRIs and stimulants in the treatment of the symptoms of nar colepsy.
References
A new method for measuring daytime sleepiness: the Epworth sleepiness scale.
TL;DR: The development and use of a new scale, the Epworth sleepiness scale (ESS), is described, which is a simple, self-administered questionnaire which is shown to provide a measurement of the subject's general level of daytime sleepiness.
16.3K
Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior
Takeshi Sakurai,Akira Amemiya,Makoto Ishii,Ichiyo Matsuzaki,Richard M. Chemelli,Hirokazu Tanaka,S. Clay Williams,James A. Richardson,Gerald P. Kozlowski,Shelagh Wilson,Jonathan R.S. Arch,Robin E. Buckingham,Andrea C. Haynes,Steven A. Carr,Roland S. Annan,Dean E. McNulty,Wu Schyong Liu,Jonathan A. Terrett,Nabil Elshourbagy,Derk J. Bergsma,Masashi Yanagisawa +20 more
TL;DR: Two novel neuropeptides are identified, both derived from the same precursor by proteolytic processing, that bind and activate two closely related (previously) orphan G protein-coupled receptors in the hypothalamus of rats.
5.6K
The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity
L de Lecea,Thomas S. Kilduff,Christelle Peyron,Xiao-Bing Gao,Pamela E. Foye,Patria E. Danielson,C. Fukuhara,Elena Battenberg,Vigdis T. Gautvik,Frederick S. Bartlett,Wayne N. Frankel,A. N. van den Pol,Floyd E. Bloom,Kaare M. Gautvik,J G Sutcliffe +14 more
TL;DR: A hypothalamus-specific mRNA is described that encodes preprohypocretin, the putative precursor of a pair of peptides that share substantial amino acid identities with the gut hormone secretin, suggesting that the hypocretins function within the CNS as neurotransmitters.
The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene
Ling Lin,Juliette Faraco,Robin Li,Hiroshi Kadotani,William J. Rogers,X. Lin,Xiaohong Qiu,Pieter J. de Jong,Seiji Nishino,Emmanuel Mignot +9 more
TL;DR: It is determined that canine narcolepsy is caused by disruption of the hypocretin (orexin) receptor 2 gene (Hcrtr2) and this result identifies hypocretins as major sleep-modulating neurotransmitters and opens novel potential therapeutic approaches for Narcoleptic patients.
2.6K
A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains
Christelle Peyron,Juliette Faraco,William J. Rogers,Beth Ripley,Sebastiaan Overeem,Sebastiaan Overeem,Yves Charnay,Sona Nevsimalova,Michael S. Aldrich,David Reynolds,Roger L. Albin,Robin Li,Marcel Hungs,Mario Pedrazzoli,Muralidhara Padigaru,Melanie H. Kucherlapati,Jun Fan,Richard A. Maki,Gert Jan Lammers,Constantin Bouras,Raju Kucherlapati,Seiji Nishino,Emmanuel Mignot +22 more
TL;DR: In situ hybridization of the perifornical area and peptide radioimmunoassays indicated global loss of hypocretins, without gliosis or signs of inflammation in all human cases examined, indicating most cases of human narcolepsy are associated with a deficient hypocretin system.
2.1K